Literature DB >> 10669351

Maternal antibody transfer in baboons and mice vaccinated with a group B streptococcal polysaccharide conjugate.

L C Paoletti1, J Pinel, R C Kennedy, D L Kasper.   

Abstract

Two animal models were used to study maternal transfer of antibody to a group B Streptococcus (GBS) type III polysaccharide-tetanus toxoid (III-TT) conjugate. The III-TT vaccine protected all 27 mouse pups born to vaccinated dams against a GBS challenge. In a separate study of vaccinated mouse dams and pups, maternal sera contained all 4 subclasses of polysaccharide-specific IgG, with IgG1 accounting for 83% of total IgG. Specific IgG subclass distribution (IgG1>>IgG2a=IgG2b=IgG3) in newborn pups closely resembled that in their mothers. Seven of 9 female baboons given the III-TT vaccine had 5- to 36-fold increases in specific antibody from baseline levels; they transferred 26%-185% of specific antibody to their offspring. Matched maternal and neonatal sera obtained at delivery were functionally equivalent in an in vitro opsonophagocytosis assay. These preclinical studies provide further evidence for effective immunogenicity of GBS conjugate vaccine and efficient transport of functionally active maternal antibody.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10669351     DOI: 10.1086/315285

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Maternal alloimmune IgG causes anti-glomerular basement membrane disease in perinatal transgenic mice that express human laminin α5.

Authors:  Dale R Abrahamson; Brooke M Steenhard; Larysa Stroganova; Adrian Zelenchuk; Patricia L St John; Margaret G Petroff; Manuel Patarroyo; Dorin Bogdan Borza
Journal:  Kidney Int       Date:  2019-07-10       Impact factor: 10.612

Review 2.  Therapeutic and prevention strategies against human enterovirus 71 infection.

Authors:  Chee Choy Kok
Journal:  World J Virol       Date:  2015-05-12

3.  Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunization.

Authors:  X Shen; T Lagergård; Y Yang; M Lindblad; M Fredriksson; J Holmgren
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

4.  Immunization of female mice with glycoconjugates protects their offspring against encapsulated bacteria.

Authors:  Margret Y Richter; Håvard Jakobsen; Alda Birgisdottir; Jean-François Haeuw; Ultan F Power; Giuseppe Del Giudice; Antonella Bartoloni; Ingileif Jonsdottir
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

5.  Pathology Associated With Streptococcus spp. Infection in Baboons (Papio spp.).

Authors:  Katelin L Davis; Olga Gonzalez; Shyamesh Kumar; Edward J Dick
Journal:  Vet Pathol       Date:  2020-08-03       Impact factor: 2.221

6.  Lymphocyte modulation in a baboon model of immunosenescence.

Authors:  Lakshmi Jayashankar; Kathleen M Brasky; John A Ward; Roberta Attanasio
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

7.  Neither antibody to a group B streptococcal conjugate vaccine nor the vaccine itself is teratogenic in rabbits.

Authors:  Lawrence C Paoletti; Hilde-Kari Guttormsen; Mildred S Christian; Alan M Hoberman; Pamela McInnes
Journal:  Hum Vaccin       Date:  2008-11-21

8.  TLR4-dependent adjuvant activity of Neisseria meningitidis lipid A.

Authors:  Susu Zughaier; Liana Steeghs; Peter van der Ley; David S Stephens
Journal:  Vaccine       Date:  2007-04-02       Impact factor: 3.641

Review 9.  Maternal vaccination: moving the science forward.

Authors:  Azure N Faucette; Benjamin L Unger; Bernard Gonik; Kang Chen
Journal:  Hum Reprod Update       Date:  2014-07-11       Impact factor: 15.610

10.  Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein.

Authors:  Denis Martin; Stéphane Rioux; Edith Gagnon; Martine Boyer; Josée Hamel; Nathalie Charland; Bernard R Brodeur
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.